A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy

Small-cell lung cancer (SCLC) is one of the most aggressive cancers, yet the molecular mechanisms underlying its devastating clinical outcome remain elusive. In this study, we investigated whether microRNA (miRNA) expression profiles can predict the clinical outcomes of SCLC patients. A total of 82...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Nan, Cao, Jianzhong, Song, Yongmei, Shen, Jie, Liu, Wenyang, Fan, Jing, He, Jie, Shi, Yuankai, Zhang, Xun, Lu, Ning, Zhan, Qimin, Wang, Luhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956664/
https://www.ncbi.nlm.nih.gov/pubmed/24637927
http://dx.doi.org/10.1371/journal.pone.0091388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956664/
https://www.ncbi.nlm.nih.gov/pubmed/24637927
http://dx.doi.org/10.1371/journal.pone.0091388

Ejemplares similares